Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Industry News, A-Z
Table bottom

Google News
Table bottom

My Settings
Personal Info
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Aerospace & Defense
Alternative Energy
Natural Disaster
Table bottom

Asthma & Allergy
Shire Announces New HELP Study(TM) Data for Lanadelumab in Hereditary Angioedema (HAE) at 2018 ACAAI Annual Scientific Meeting - Data shows lanadelumab provides significant, clinically meaningful reduction of HAE attacks throughout...
Globe Newswire, 2:03am ET

The Global Medicinal Mushroom Market is expected to reach USD 78765.65million by 2025, from USD 38108.68 million in 2017 growing at a CAGR of 9.5% during the forecast period of 2018 to 2025. For In depth Information Get Sample Copy of this...
ABNewswire, 10:28pm ET

The California wildfires are not just affecting those directly in their path, but affecting millions of residents who are now breathing in the hazardous air conditions. Doctor On Demand, the nation's leading virtual care...
BusinessWire, 9:13pm ET

Fluid Management Systems Market is having several developments, product launches, joint ventures, merges and accusations by its prominent market players and top brands which are driving the market in the terms of sales, import, export and...
ABNewswire, 6:53pm ET

Market Scenario: Ayurveda, although a traditional Indian healing system, worldwide, it has long been recognized as an effective alternative treatment, being offered in therapeutic practices.  It takes a holistic approach to...
ABNewswire, 6:03pm ET

Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label for Promacta® (eltrombopag) to include first-line treatment for adults and pediatric patients two years and older with SAA in combination with...
PR Newswire, 4:48pm ET

Novartis International AG / FDA approves Novartis drug Promacta(R) for first-line SAA and grants Breakthrough Therapy designation for additional new indication . Processed and transmitted by West Corporation. The issuer is solely responsible...
Globe Newswire, 4:38pm ET

SmarTrend identified an Uptrend for Meridian Biosci (NASDAQ:VIVO) on October 24th, 2018 at $15.79. In approximately 3 weeks, Meridian Biosci has returned 21.56% as of today's recent price of $19.20. In the past 52 weeks, Meridian Biosci...
Comtex SmarTrend(R), 1:13pm ET

The "Precision Medicine (Diagnostics/Therapeutics) Market Analysis Report By Application (Genetic Tests, Esoteric Tests, Pharmaceuticals, Medical Devices), By End Use, And Segment Forecasts, 2018 - 2025" report has been added to...
PR Newswire, 12:38pm ET

The "Caffey's Pediatric Diagnostic Imaging, 2-Volume Set. Edition No. 13" book has been added to's offering. For more than 70 years, Caffey's Pediatric Diagnostic Imaging has been the...
BusinessWire, 12:28pm ET

Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm"), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI(R) Technology products that are used to treat patients of all ages...
BusinessWire, 12:03pm ET

New York, November 16, 2018: The home healthcare market is expected to exceed more than US$ 349 billion by 2020. Endoscopy is a process in which a flexible tube is been attached by a tiny camera with the help of that the doctors examine...
Heraldkeeper, 9:08am ET

New York, November 16, 2018: The Global Infection Control Market is expected to exceed more than US$ 18.00 Billion by 2022 at a CAGR of 6.5% in the given forecast period. Infections are principally caused by microorganisms like bacterium,...
Heraldkeeper, 9:08am ET

Seqirus, a wholly owned subsidiary of CSL Limited and a global leader in influenza prevention, today announced a $140M expansion of its Holly Springs manufacturing facility in North Carolina. The Holly Springs facility is at the center of a...
PR Newswire, 9:08am ET

Conference call with live audio webcast on Tuesday, November 20th at 8:30 am ET Immune Pharmaceuticals, Inc. (OTCQB: IMNP) ("Immune" or the "Company"), a biopharmaceutical company developing novel therapeutic agents for the treatment of...
GlobeNewswire, 8:38am ET

The "Precision Medicine (Diagnostics/Therapeutics) Market Analysis Report By Application (Genetic Tests, Esoteric Tests, Pharmaceuticals, Medical Devices), By End Use, And Segment Forecasts, 2018 - 2025" report has...
BusinessWire, 8:33am ET

Seqirus, a global leader in influenza prevention, today released a new real-world evidence analysis indicating that its cell-based quadrivalent influenza vaccine (QIVc) was 36.2 percent more effective than standard egg-based quadrivalent vaccine...
PR Newswire, 8:08am ET

--Acquisition and Program Agreement Strengthen TIAA's Services for Healthcare Institutions TIAA Bank announced today the acquisition of a $1.5 billion portfolio of healthcare equipment leases and loans from GE Capital's Healthcare...
BusinessWire, 8:08am ET

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Chief Medical Officer Richard Scranton, M.D., M.P.H., was one of three industry representatives invited to provide insight and perspective during the U.S. Food and Drug...
GlobeNewswire, 7:38am ET

BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today presented data showing that an oral formulation of BCX7353 was rapidly absorbed and exhibited a long half-life, two important characteristics of desired new acute treatments for hereditary...
GlobeNewswire, 7:13am ET

1-20 of 27
Next 7 >>

Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, No redistribution allowed.